IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q1 2022 Holdings

Filed 2022-05-16 | 10 holdings | $281.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Progenity Inc.Note 7.250% 12/074319FAB3$73.7K$103,500,00026.2%
Amryt Pharma PLCSponsored ADS03217L106$73.3K8,857,26826.0%
Progenity Inc.COM74319F107$34.6K29,855,84712.3%
Caremax IncCOM CL A14171W103$33.5K4,487,21911.9%
Omeros CorpNOTE 6.250%11/1682143AE2$20.1K$21,005,0007.1%
RVL Pharmaceuticals PLCSHSG6S41R101$13.8K8,148,8324.9%
Omeros CorpNOTE 5.250% 2/1682143AG7$13.5K$18,000,0004.8%
BridgeBio Pharma Inc.NOTE 2.250% 2/010806XAD4$9.7K$20,000,0003.4%
Puma Biotechnology Inc(PBYI)COM74587V107$5.2K1,792,1141.8%
Societal Cdmo Inc.Com75629F109$4.0K2,202,4201.4%